Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 945Treatment of Major DepressionMental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 59 of the 63 references it cites were found in a registry or an index.

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

Geddes, John R, Carney, Stuart M, Davies, Christina, Furukawa, Toshiaki A, Kupfer, David J, Frank, Ellen, Goodwin, Guy M·2003·The Lancet

Abstract

Background Antidepressant drugs can promote remission from acute depressive episodes. Our aim was to establish how long such treatments should be continued to prevent relapse. Method We did a systematic overview of evidence from randomised trials of continuing treatment with antidepressants in patients with depressive disorders who have responded to acute treatment. Medline, Embase, Cinahl, PsycLIT, Psyndex, and Lilacs were searched. Findings Data were pooled from 31 randomised trials (4410 participants). Continuing treatment with antidepressants reduced the odds of relapse by 70% (95% CI 62-78; 2p Interpretation Antidepressants reduce the risk of relapse in depressive disorder, and continued treatment with antidepressants would benefit many patients with recurrent depressive disorder. The treatment benefit for an individual patient will depend on their absolute risk of relapse with greater absolute benefits in those at higher risk. Further trials are needed to establish the optimum length of therapy and should include patients who were not well represented in these trials, including those at low risk of relapse.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(03)12599-8

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

24 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 63 references

Research works printed but not linked: 4

  1. 2000, Practice guideline for the treatment of patients with major depressive disorder (revision), Am J Psychiatry, 157, 1
  2. Eric, 1991, A prospective double-blind comparative multi-centre study of paroxetine in preventing recurrent major depressive episodes, Biol Psychiatry, 29, 11
  3. Lendresse, 1985, Traitement prolongé par nomifensine 75mg dans les états dépressifs neurotiques et reactionnels, Psychiatrie Francaise, 16, 156
  4. Rouillon, 1989, Rechutes de dépression unipolaire et efficacité de la maprotiline, Encephale, 15, 527

Cited by

See all 945

Metadata

Authors
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M.
Affiliations
  • Warneford Hospital (GB)
  • University of Oxford (GB)
  • UPMC Health System (US)
Corresponding author
Geddes, John R
Venue
The Lancet
Publisher
Elsevier BV
Published
2003-02
Volume
361
Issue
9358
Pages
653-661
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2133308299
Cited by
945
References
63
Citations by year
2026: 15 · 2025: 20 · 2024: 27 · 2023: 23 · 2022: 23 · 2021: 39 · 2020: 61 · 2019: 33 · 2018: 31 · 2017: 39 · 2016: 65 · 2015: 39 · 2014: 46 · 2013: 41 · 2012: 52
FWCI
5.21
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
Wellcome Trust
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
antidepressants, relapse prevention, depressive disorders, recurrent depression, continuation treatment, treatment discontinuation, remission, medication adherence, placebo response, treatment duration
MeSH terms
Antidepressive Agents, Depressive Disorder, Humans, Randomized Controlled Trials as Topic, Treatment Outcome, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. https://app.cochat.ai/papers/10.1016/s0140-6736(03)12599-8
The paper
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. The Lancet. https://doi.org/10.1016/s0140-6736(03)12599-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.